These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7301482)

  • 1. [Usefulness of determination of concentrations of catecholamines and their metabolites in the urine of children with neuroblastoma for diagnostic purposes, control of the course and evaluation of the results of therapy].
    Prokopczyk J; Wańkowicz B; Wenzel E
    Pediatr Pol; 1981 Aug; 56(8):883-8. PubMed ID: 7301482
    [No Abstract]   [Full Text] [Related]  

  • 2. [The importance of the determination of urinary catecholamines and urinary vanilmandelic acid in the diagnosis and control of neuroblastoma therapy].
    Rutiloni C; Serra GB
    Minerva Pediatr; 1968 Dec; 20(48):2481-7. PubMed ID: 5715834
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroblastoma: the challenge and frustration.
    Finklestein JZ
    Hematol Oncol Clin North Am; 1987 Dec; 1(4):675-94. PubMed ID: 3323179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.
    Strenger V; Kerbl R; Dornbusch HJ; Ladenstein R; Ambros PF; Ambros IM; Urban C
    Pediatr Blood Cancer; 2007 May; 48(5):504-9. PubMed ID: 16732582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of neuroblastoma by qualitative and quantitative determination of catecholamine metabolites in urine.
    Gitlow SE; Bertani LM; Rausen A; Gribetz D; Dziedzic SW
    Cancer; 1970 Jun; 25(6):1377-83. PubMed ID: 5422912
    [No Abstract]   [Full Text] [Related]  

  • 6. [The significance of the determination of catecholamines and their metabolites in neuroblastomas].
    Szücs L; Gimesi A; Schuler D; Nagy I
    Z Med Lab Diagn; 1990; 31(8):421-5. PubMed ID: 2095056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary catecholamines and their metabolites in management of neuroblastoma.
    Eldeeb BB; Hammond EM; Worthington DJ; Mann JR
    Pediatr Hematol Oncol; 1988; 5(3):229-37. PubMed ID: 3152967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recommended methods for the determination of catecholamines and their metabolites in urine. Significance of results in the diagnosis and follow-up of pheochromocytoma and neuroblastoma].
    Revol A; Comoy E; Forzy G; Garnier JP; Gerhardt MF; Hirth C; Jacob N; Mathieu P; Patricot MC; Peyrin L
    Ann Biol Clin (Paris); 1994; 52(9):625-37. PubMed ID: 7872511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuroblastoma. Results of protocol N-I-87].
    Castel Sánchez V; Badal Iranzo MD; Bezanilla Regato JL; Herrero Díez A; Llombart Bosch A; Ruiz Jiménez JI; Sánchez de Toledo J
    An Esp Pediatr; 1993 May; 38(5):471-6. PubMed ID: 8503598
    [No Abstract]   [Full Text] [Related]  

  • 10. Paediatric reference ranges for urinary catecholamines/metabolites and their relevance in neuroblastoma diagnosis.
    Fitzgibbon MC; Tormey WP
    Ann Clin Biochem; 1994 Jan; 31 ( Pt 1)():1-11. PubMed ID: 8154845
    [No Abstract]   [Full Text] [Related]  

  • 11. [Neuroblastoma in childhood. Review of clinical aspects and of 2 forms of treatment].
    Zambudio Carmona GA; Ruiz Jiménez JI; Gutiérrez Canto MA; Tujillo Ascanio A; Vera M
    Cir Pediatr; 1993 Apr; 6(2):55-8. PubMed ID: 8357722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroblastoma: new approaches to diagnosis.
    Kemshead JT; Lashford LS; Garson J; Clayton J
    Cancer Surv; 1987; 6(2):227-246. PubMed ID: 3322546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical appearance of neuroblastoma 10 years after screening.
    Kerbl R; Urban CE; Zotter H; Lackner H; Sovinz P; Ambros PF
    Pediatr Blood Cancer; 2007 Dec; 49(7):1012-4. PubMed ID: 16534792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Features of neuroblastoma in African children.
    Familusi JB; Aderele WI; Williams OA
    East Afr Med J; 1978 Apr; 55(4):182-90. PubMed ID: 679869
    [No Abstract]   [Full Text] [Related]  

  • 15. Urinary VMA, dopamine and the likelihood of neuroblastoma: a preferred way of reporting laboratory results?
    Sies CW; Florkowski CM; Sullivan M; Mackay R; George PM
    Ann Clin Biochem; 2006 Jul; 43(Pt 4):300-5. PubMed ID: 16824281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of catecholamine metabolites in urine by mass fragmentography with application to diagnostic examination.
    Bando K; Hayashi C; Miyai K
    Med J Osaka Univ; 1981 Mar; 31(3-4):101-10. PubMed ID: 7311911
    [No Abstract]   [Full Text] [Related]  

  • 17. Interpretation of random urinary catecholamines and their metabolites in neuroblastoma.
    O'Meara A; Tormey W; FitzGerald RJ; Fitzgibbon M; Kenny D
    Acta Paediatr; 1994 Jan; 83(1):88-92. PubMed ID: 8193481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The diagnostic significance of the determination of catecholamines and their metabolites].
    Käser H
    Schweiz Med Wochenschr; 1966 Feb; 96(8):258-62. PubMed ID: 5983012
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of neuroblastoma.
    Schweisguth O
    J Pediatr Surg; 1968 Feb; 3(1):183-7. PubMed ID: 5655573
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biochemical diagnosis of pheochromocytoma and neuroblastomas].
    Candito M; Billaud E; Chauffert M; Cottet-Emard JM; Desmoulin D; Garnier JP; Greffe J; Hirth C; Jacob N; Millot F; Nignan A; Patricot MC; Peyrin L; Plouin PF
    Ann Biol Clin (Paris); 2002; 60(1):15-36. PubMed ID: 11830391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.